Market Insight: Agrigenomics Moves from Genomic Research Toward Commercial Agricultural Applications

The global agrigenomics market is valued at USD 5 billion in 2026, is estimated at USD 5.38 billion in 2027, and is projected to reach USD 11.87 billion by 2036, expanding at a 9.03% CAGR from 2027 to 2036. This trajectory reflects a broader shift in agriculture from conventional breeding toward data-driven genetic improvement, where sequencing, gene editing, and genomic analysis increasingly support decisions across crops and livestock. The market is gaining momentum because genomic technologies can help identify valuable traits, improve breeding precision, strengthen disease-resistance programs, and support the development of crops better suited to changing environmental conditions.

The crop application segment remains central to market development because genomic tools are increasingly embedded in trait improvement, seed development, disease resistance, and yield optimization programs. Agrigenomics is therefore moving beyond laboratory research into commercial breeding pipelines, where faster identification of desirable genetic characteristics can shorten development cycles and improve the efficiency of agricultural innovation.

Another important development is the growing integration of genomics with precision agriculture and sensor-based systems. Combining genetic information with field-level data can give breeders and agricultural producers a more comprehensive view of crop performance. This convergence creates opportunities for sequencing providers, agricultural biotechnology companies, data-platform developers, and breeding organizations to develop integrated solutions rather than isolated genomic products.

The livestock side of the market is also gaining strategic importance. Recent advances in gene editing demonstrate how genomic technologies can move from research environments toward commercially relevant animal-production applications. As agricultural producers face pressure to improve productivity while addressing disease resistance, resource efficiency, and sustainability, agrigenomics is increasingly positioned as an enabling technology across both crop and animal production.

Regional Analysis: North America's Established Base Meets Asia Pacific's Expansion Potential

North America currently represents the leading regional market for agrigenomics, supported by advanced sequencing capabilities, established agricultural biotechnology infrastructure, and broad commercial adoption of genomic technologies. The region benefits from the presence of major sequencing, genomics, and agricultural biotechnology companies, creating an ecosystem in which research institutions, technology providers, breeders, and commercial agriculture can interact closely.

The maturity of North America's genomics infrastructure gives companies opportunities to commercialize sophisticated sequencing and analysis solutions across both crop and livestock applications. Established research capabilities also support the adoption of advanced platforms where high-resolution genomic information is required for complex breeding programs.

Asia Pacific presents a different market dynamic. Rather than being defined primarily by an established installed base, its opportunity is linked to expanding precision agriculture adoption and the increasing use of genomic technologies for crop improvement and livestock productivity. The region's growing agricultural technology ecosystem creates opportunities for sequencing providers and biotechnology companies to expand applications beyond traditional research environments.

The contrast between the regions is therefore strategically important. North America provides a developed environment for technology commercialization and advanced applications, while Asia Pacific offers substantial room for adoption expansion. Companies operating internationally can address these differences through region-specific strategies, emphasizing sophisticated genomic workflows in mature markets while building accessibility and application awareness in developing agricultural technology environments.

Industry Challenge: Scaling Genomic Innovation into Practical Agricultural Workflows

One of the key challenges for agrigenomics is converting increasingly sophisticated genomic capabilities into scalable and practical agricultural workflows. Advanced sequencing can generate extensive genetic information, but the commercial value of that information depends on how efficiently it can be processed, interpreted, and incorporated into breeding or production decisions.

Sample preparation and laboratory workflow efficiency are particularly important. As genomic applications expand, laboratories need systems capable of handling larger volumes of samples without compromising consistency. The development of automated sample-preparation instruments reflects this requirement and indicates that laboratory infrastructure is becoming an important component of agrigenomics commercialization.

Another challenge is the complexity of agricultural genomes. Crop and animal genomes can require deeper analysis to identify meaningful genetic characteristics, particularly when breeding programs target multiple traits simultaneously. This increases the importance of sequencing platforms capable of generating high-quality information and analytical systems that can convert genomic data into actionable insights.

Commercialization can also be affected by regulatory considerations, particularly for gene-edited agricultural products. The approval of gene-edited livestock demonstrates progress toward commercial deployment, but regulatory pathways remain an important consideration for companies developing engineered crops and animals.

As a result, future market development will depend not only on sequencing performance but also on workflow automation, data interpretation, regulatory navigation, and integration with existing agricultural production systems.

Product and Technology Comparison: Illumina Hi Seq Family versus PacBio Sequencing

Within the sequencing landscape, Illumina Hi Seq systems and PacBio Sequencing represent different technology opportunities within agrigenomics.

Illumina Hi Seq Family is associated with established sequencing workflows and has a strong role in the crop application landscape. Its relevance is particularly apparent in agricultural research programs where genomic information is used for trait identification, breeding analysis, and broader crop-improvement initiatives. Established sequencing infrastructure can also support laboratories that require repeatable workflows across larger research programs.

PacBio Sequencing, by contrast, is identified as the fastest-growing sequencer segment. Its momentum is associated with demand for deeper genomic resolution and improved analysis of complex plant and animal genomes. This makes the technology particularly relevant where conventional genomic approaches may not provide sufficient resolution for advanced breeding requirements.

The distinction creates different commercial opportunities. Established sequencing platforms can benefit from existing laboratory infrastructure, familiarity, and broad research applications, while advanced sequencing approaches can capture demand generated by increasingly complex genomic analysis requirements.

For agrigenomics companies, the competitive opportunity is therefore not limited to choosing between sequencing technologies. Providers can differentiate through sample preparation, automation, analytical software, workflow integration, and specialized applications for crop or livestock breeding. The expanding complexity of agricultural genomics creates space for multiple sequencing approaches to coexist across different research and commercial use cases.

Geographic Opportunity: Markets with Strategic Agrigenomics Relevance

United States

The United States represents an important agrigenomics market because North America is the established regional leader and several major companies active in sequencing, agricultural biotechnology, and livestock genetics operate in the country. Recent commercial activity in gene-edited livestock also highlights the country's role in translating agricultural biotechnology research into market-oriented applications.

China

China is strategically relevant because Asia Pacific represents the high-growth regional hub and Chinese companies are already represented among the prominent participants in the agrigenomics ecosystem. Continued development of genomic research, agricultural biotechnology, and crop-improvement capabilities creates opportunities for technology suppliers and specialized genomic service providers.

United Kingdom

The United Kingdom has relevance through its participation in the broader genomics ecosystem, including companies involved in sequencing and genomic workflow development. Its position within the European research and biotechnology landscape can support applications spanning agricultural research, laboratory services, and advanced genomic analysis.

Switzerland

Switzerland represents another relevant technology market through the presence of genomics and sequencing-related companies. Its strategic importance is linked to advanced life-science capabilities and participation in specialized genomic technology development, providing an environment for solutions focused on high-quality sequencing and laboratory workflows.

Competitive Landscape: From Sequencing Platforms to End-to-End Agricultural Genomics

The competitive environment includes major technology providers such as Thermo Fisher Scientific, Illumina, Agilent Technologies, Eurofins Scientific, BGI Genomics, LGC, Tecan Group, Arbor Biosciences, Neogen Corporation, and Inari. Their activities reveal that competition is developing across multiple layers of the agrigenomics value chain rather than being concentrated solely on sequencing instruments.

Sequencing and analytical capabilities remain foundational, with established providers supporting agricultural research and genomic workflows. At the same time, laboratory automation is becoming increasingly relevant. QIAGEN's plans to develop automated sample-preparation instruments indicate a focus on improving throughput and scalability, which can become increasingly important as genomic testing expands.

Gene editing is another major competitive direction. Inari's funding activity to scale its multiplex gene-editing platform demonstrates the industry's movement toward technologies designed not simply to analyze agricultural genetics but to directly modify traits for crop improvement.

Livestock genetics represents another area of commercial development. Genus's regulatory milestone involving gene-edited PRRS-resistant pigs illustrates how genomic technologies are progressing toward practical animal-production applications.

Overall, competitive positioning is increasingly shaped by the ability to connect sequencing, sample preparation, genomic analysis, gene editing, and agricultural applications into commercially useful workflows.

Recent Industry News: Key Developments Shaping Agrigenomics

Genus — May 2025: Gene-Edited Livestock Moves Toward Commercial Deployment

In May 2025, Genus received FDA approval for gene-edited PRRS-resistant pigs, marking an important regulatory development for agricultural biotechnology. The milestone supports the movement of gene-edited livestock from development programs toward commercial deployment in the United States. It also demonstrates the growing relevance of genomic technologies beyond crop breeding, particularly in animal health and production efficiency.

QIAGEN — April 2025: Automation Expands Genomic Workflow Capabilities

In April 2025, QIAGEN announced plans to develop automated sample-preparation instruments targeted for launch in 2026. The initiative expands the company's laboratory automation portfolio and addresses the need for scalable genomic workflows. Greater automation can help laboratories improve sample-processing efficiency as agricultural and life-science genomic applications become more data-intensive.

Inari — January 2025: Funding Supports Multiplex Gene-Editing Expansion

In January 2025, Inari secured USD 144 million in funding to scale its multiplex gene-editing platform for row crops. The capital supports expansion of gene-editing capabilities focused on crop-performance traits and strengthens the company's ability to advance engineered seed technologies toward commercialization.

Illumina and LGC Biosearch — September 2024: Sequencing Workflow Integration

In September 2024, Illumina and LGC Biosearch entered a partnership integrating Amp-Seq sample preparation with Illumina sequencing chemistry for researchers across Asia Pacific and South America. The collaboration is significant because improved workflow compatibility can make genomic technologies more accessible across agricultural research environments and support broader adoption of sequencing-based approaches.

Tecan Genomics — February 2023: Automation and Sequencing Integration

In February 2023, Tecan Genomics collaborated with Singular Genomics to integrate the MagiPrep NGS system with the G4 sequencing platform. The integration connects automation with sequencing workflows, highlighting the industry's continuing emphasis on streamlining library preparation and improving end-to-end genomic processing efficiency for agricultural and life-science research.

Read more about this report @ https://www.fundamentalbusinessinsights.com/industry-report/agrigenomics-market-14885

About

Fundamental Business Insights:

Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.

Contact us:
Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email:  sales@fundamentalbusinessinsights.com

Read This Report in Regional Languages - 

https://www.fundamentalbusinessinsights.com/ko/industry-report/agrigenomics-market-14885

https://www.fundamentalbusinessinsights.com/ja/industry-report/agrigenomics-market-14885

https://www.fundamentalbusinessinsights.com/de/industry-report/agrigenomics-market-14885

https://www.fundamentalbusinessinsights.com/it/industry-report/agrigenomics-market-14885

https://www.fundamentalbusinessinsights.com/es/industry-report/agrigenomics-market-14885

https://www.fundamentalbusinessinsights.com/fr/industry-report/agrigenomics-market-14885